Emerging Tools for Stroke Prevention in Atrial Fibrillation

Emerging Tools for Stroke Prevention in Atrial Fibrillation

Ischaemic strokes resulting from atrial fibrillation (AF) constitute a devastating condition for patients and their carers with huge burden on health care systems. Prophylactic treatment against systemic embolization and ischaemic strokes is the cornerstone for the management of AF. Effective stroke...

Full description

Bibliographic Details
Main Authors:	Christos Voukalis, Gregory Y.H. Lip, Eduard Shantsila
Format:	Article
Language:	English
Published:	Elsevier 2016-02-01
Series:	EBioMedicine
Subjects:	Atrial fibrillation Stroke prevention Risk stratification Oral anticoagulation Non-vitamin K oral anticoagulants Net clinical benefit
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396416300135

Similar Items

Atrial Fibrillation and Stroke. A Review on the Use of Vitamin K Antagonists and Novel Oral Anticoagulants
by: Alfredo Caturano, et al.
Published: (2019-09-01)

Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA‐AF Phase III Registry
by: Valentina Bayer, et al.
Published: (2022-03-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Anna Szpotowicz, et al.
Published: (2021-10-01)

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation
by: Chern-En Chiang, MD, PhD, et al.
Published: (2017-08-01)

Management and Prognosis of Acute Stroke in Atrial Fibrillation
by: Mette F. Hindsholm, et al.
Published: (2023-09-01)

Stroke prevention in atrial fibrillation: findings from Tuscan FADOI Stroke Registry
by: Luca Masotti, et al.
Published: (2014-06-01)

Early Anticoagulation in Patients with Acute Ischemic Stroke Due to Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Lina Palaiodimou, et al.
Published: (2022-08-01)

Predictors for Adherence to Recommended Anticoagulation after Stroke Unit Discharge in Patients with Atrial Fibrillation
by: Theresa Frank, et al.
Published: (2024-02-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Contemporary trends and barriers to oral anticoagulation therapy in Non-valvular atrial fibrillation during DOAC predominant era
by: Ojasav Sehrawat, et al.
Published: (2023-06-01)

THE APPROPRIATENESS OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN REAL CLINICAL PRACTICE
by: A. Y. RYCHKOV, et al.
Published: (2016-12-01)

GLOBAL CLINICAL PRACTICE AND PERSONALIZED CHOICES FOR ORAL ANTICOAGULANT THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION
by: A. V. Fonyakin, et al.
Published: (2016-12-01)

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry
by: Xiaoxia Liu, et al.
Published: (2023-08-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation
by: A. A. Kulesh, et al.
Published: (2022-12-01)

Non-Vitamin K Oral Anticoagulants Assessment in High Risk of Bleeding Patients with Non-Valvular Atrial Fibrillation
by: Pedro Silva Cunha, et al.
Published: (2022-02-01)

Occurrence of Ischemic Stroke in Patients With Atrial Fibrillation Receiving Non-Vitamin K Oral Anticoagulants: Causes and Prevention Strategies
by: Oh Young Bang, et al.
Published: (2023-05-01)

Net clinical benefit of oral anticoagulants in Korean atrial fibrillation patients with low to intermediate stroke risk: A report from the Clinical Survey on Stroke Prevention in patients with Atrial Fibrillation (CS‐SPAF)
by: Moonki Jung, et al.
Published: (2023-06-01)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
by: Suárez Fernández C, et al.
Published: (2018-02-01)

Difficult issues in the management of patients with atrial fibrillation: a neurologist's point of view
by: A. A. Kulesh
Published: (2021-10-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01)

Atrial fibrillation: estimated excess rate of stroke due to lacking adherence to guidelines
by: BS Zehnder
Published: (2006-12-01)

Stroke in Patients with Atrial Fibrillation: Epidemiology, Screening, and Prognosis
by: Olli Pekka Suomalainen, et al.
Published: (2023-12-01)

Non-Pharmacological Stroke Prevention in Atrial Fibrillation
by: Iñigo Anduaga, et al.
Published: (2023-08-01)

Survey Study of the Real‐World Outpatient Management of Postoperative Atrial Fibrillation
by: Nirav V. Patel, et al.
Published: (2023-05-01)

PRACTICAL APPLICATION OF DABIGATRAN ETEXILATE FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION
by: E. D. Kosmacheva, et al.
Published: (2015-09-01)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
by: Adane Teshome Kefale, et al.
Published: (2023-09-01)

ATRIAL FIBRILLATION IN PATIENTS WITH HEMORRHAGIC STROKE: APPROACHES TO ANTICOAGULANT THERAPY
by: A. M. Kulagina, et al.
Published: (2017-05-01)

Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
by: Luciana Armaganijan, et al.
Published: (2012-04-01)

Clinical Outcomes in Patients With Atrial Fibrillation Treated With Non–Vitamin K Oral Anticoagulants Across Varying Body Mass Index
by: Astrid Fritz Hansson, et al.
Published: (2023-11-01)

A novel shared decision-making (SDM) tool for anticoagulation management in atrial fibrillation: protocol for a prospective, cluster randomized controlled trial
by: Mang-Mang Pan, et al.
Published: (2023-10-01)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)

Effects of the availability of new oral anticoagulants in patients with non-valvular atrial fibrillation in the real world: the NAIF study
by: Francesco Ventrella, et al.
Published: (2016-07-01)

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation
by: Michela Giustozzi, et al.
Published: (2020-05-01)

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system
by: José Miguel Rivera-Caravaca, et al.
Published: (2022-10-01)

Net clinical benefit of anticoagulant therapy from a neurologist's perspective: A review
by: Aleksey A. Kulesh
Published: (2022-02-01)

Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation
by: A. V. Fonyakin
Published: (2014-12-01)